Passage Bio, Inc. (PASG) Tops Q4 EPS by 2c

Passage Bio, Inc. (NASDAQ: PASG) reported Q4 EPS of ($0.50), $0.02 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Endava CFO placed on leave amid accounting probe
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold